Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

ACCORD and Risk-Factor Control in Type 2 Diabetes.

Nilsson PM.

N Engl J Med. 2010 Apr 29;362(17):1628-30. doi: 10.1056/NEJMe1002498. Epub 2010 Mar 14. No abstract available.

PMID:
20228405
2.

"If it ain't broke, don't fix it": a commentary on the positive-negative results of the ACCORD Lipid study.

Tenenbaum A, Fisman EZ.

Cardiovasc Diabetol. 2010 Jun 15;9:24. doi: 10.1186/1475-2840-9-24.

3.

Combination lipid therapy in type 2 diabetes.

Perkins WJ Jr.

N Engl J Med. 2010 Aug 12;363(7):694; author reply 694-5. No abstract available.

PMID:
20842773
4.

Reduction in risk of progression of diabetic retinopathy.

Klein BE.

N Engl J Med. 2010 Jul 15;363(3):287-8. doi: 10.1056/NEJMe1005667. Epub 2010 Jun 29. No abstract available.

PMID:
20587586
5.

Solvay addresses unmet needs in the management of hypertensive patients with cardiometabolic and lipid disorders.

[No authors listed]

Cardiovasc J Afr. 2009 Jan-Feb;20(1):73-4. No abstract available.

6.

Treating the cardiometabolic syndrome: an opportunity to provide comprehensive cardiovascular risk reduction.

Basile J, Houston M, Ferrario CM.

J Cardiometab Syndr. 2006 Fall;1(5):358-61. No abstract available.

7.

Combination lipid therapy in type 2 diabetes.

Saely CH, Rein P, Drexel H.

N Engl J Med. 2010 Aug 12;363(7):692; author reply 694-5. doi: 10.1056/NEJMc1006407. No abstract available.

8.

Combination statin-fibrate therapy: safety aspects.

Franssen R, Vergeer M, Stroes ES, Kastelein JJ.

Diabetes Obes Metab. 2009 Feb;11(2):89-94. doi: 10.1111/j.1463-1326.2008.00917.x. Epub 2008 Jun 1. Review.

PMID:
18518891
9.

Therapy and clinical trials.

Usman M, Peter R.

Curr Opin Lipidol. 2006 Oct;17(5):612-4. No abstract available.

PMID:
16960511
10.

Reducing cardiovascular risk in metabolic syndrome and type 2 diabetes mellitus beyond low-density lipoprotein cholesterol lowering: a role for fenofibrate. Introduction.

Sacks FM.

Am J Cardiol. 2008 Dec 22;102(12A):1L-3L. doi: 10.1016/j.amjcard.2008.09.066. No abstract available.

PMID:
19084082
11.

Effects of combination lipid therapy in the management of patients with type 2 diabetes mellitus in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.

Tonkin AM, Chen L.

Circulation. 2010 Aug 24;122(8):850-2. doi: 10.1161/CIRCULATIONAHA.110.960112. No abstract available.

12.

Type 2 diabetes treatment and macrovascular complications--fat and sugar make a dangerous soufflé.

Bajaj M, Jialal I.

Metab Syndr Relat Disord. 2009 Apr;7(2):79-81. doi: 10.1089/met.2008.0092. No abstract available.

PMID:
19351292
13.

[The Steno-2 study. Intensive multifactorial intervention reduces the occurrence of cardiovascular disease in patients with type 2 diabetes].

Gaede PH, Jepsen PV, Larsen JN, Jensen GV, Parving HH, Pedersen OB.

Ugeskr Laeger. 2003 Jun 23;165(26):2658-61. Danish. No abstract available.

PMID:
12886549
14.

Blood pressure control in type 2 diabetes.

Schrier RW.

N Engl J Med. 2010 Aug 12;363(7):696-7; author reply 697. No abstract available.

PMID:
20842783
15.

Blood pressure control in type 2 diabetes.

Wetzels JF.

N Engl J Med. 2010 Aug 12;363(7):695; author reply 697. doi: 10.1056/NEJMc1006411. No abstract available.

16.

Concurrent blood pressure, glycemic and lipid control for the prevention of vascular complications of type II diabetes mellitus: a long overdue objective?

Athyros VG, Mitsiou EK, Tziomalos K, Karagiannis A, Mikhailidis DP.

Curr Vasc Pharmacol. 2010 Jan;8(1):1-4. No abstract available.

PMID:
20394107
17.

[Diabetics' life is about one third shorter. So you improve the prognosis of these high-risk patients].

Stiefelhagen P.

MMW Fortschr Med. 2003 Apr 10;145(15):18, 20. German. No abstract available.

PMID:
15104261
18.

[Integrated drug therapy of the metabolic syndrome].

Julius U, Hanefeld M.

Internist (Berl). 1996 Jul;37(7):722-30. Review. German. No abstract available.

PMID:
8766266
19.

Fenofibrate and cardiovascular risk: a synopsis and commentary on (FIELD).

Bailey CJ.

Diabet Med. 2006 Feb;23(2):109-12. No abstract available.

PMID:
16433706
20.

Managing cardiovascular risk in patients with diabetes.

Rydén L.

Heart. 2000 Sep;84 Suppl 1:i23-5:discussion i50. No abstract available.

Items per page

Supplemental Content

Write to the Help Desk